Trader consensus prices a 75% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips to high-risk destinations—by December 31, 2026, driven by a cluster of new Level 2 notices in March for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya in Mayotte, and global poliovirus circulation across 30+ countries. These reflect heightened outbreak activity, compounded by a U.S. measles epidemic surpassing 1,714 confirmed cases as of April 9 per CDC data, amid declining vaccination rates and international spread risks. Persistent H5N1 avian influenza outbreaks in U.S. dairy cattle and wild birds, though with no new human infections reported last week, underscore spillover potential. Weekly CDC FluView updates and WHO surveillance reports remain key catalysts for potential escalation.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoIl CDC emette un avviso di livello 3 entro il 31 dicembre?
Il CDC emette un avviso di livello 3 entro il 31 dicembre?
Sì
$112,110 Vol.
$112,110 Vol.
Sì
$112,110 Vol.
$112,110 Vol.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercato aperto: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus prices a 75% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips to high-risk destinations—by December 31, 2026, driven by a cluster of new Level 2 notices in March for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya in Mayotte, and global poliovirus circulation across 30+ countries. These reflect heightened outbreak activity, compounded by a U.S. measles epidemic surpassing 1,714 confirmed cases as of April 9 per CDC data, amid declining vaccination rates and international spread risks. Persistent H5N1 avian influenza outbreaks in U.S. dairy cattle and wild birds, though with no new human infections reported last week, underscore spillover potential. Weekly CDC FluView updates and WHO surveillance reports remain key catalysts for potential escalation.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti